{"id":16528,"date":"2025-01-15T09:26:06","date_gmt":"2025-01-15T09:26:06","guid":{"rendered":"https:\/\/www.info-welt.com\/en\/index.php\/2025\/01\/15\/hepatitis-c-vaccine-latest-research-prevention-updates\/"},"modified":"2025-01-15T09:26:06","modified_gmt":"2025-01-15T09:26:06","slug":"hepatitis-c-vaccine-latest-research-prevention-updates","status":"publish","type":"post","link":"https:\/\/www.info-welt.com\/en\/index.php\/2025\/01\/15\/hepatitis-c-vaccine-latest-research-prevention-updates\/","title":{"rendered":"Hepatitis C Vaccine: Latest Research &amp; Prevention Updates"},"content":{"rendered":"<p><b>Hepatitis C virus<\/b> (HCV) remains a major global health issue. Scientists are working hard to create an effective vaccine against this <b>liver disease<\/b><sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.fda.gov\/vaccines-blood-biologics\/science-research-biologics\/new-approaches-development-and-evaluation-vaccines-against-hepatitis-viruses\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">1<\/a><\/sup>. Grasping the virus\\&#8217;s complexity is key to stopping its spread and preventing liver problems<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.cdc.gov\/hepatitis-c\/prevention\/index.html\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">2<\/a><\/sup>.<\/p>\n<p>Millions worldwide are affected by HCV. About 3.2 million Americans have chronic HCV infection<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.fda.gov\/vaccines-blood-biologics\/science-research-biologics\/new-approaches-development-and-evaluation-vaccines-against-hepatitis-viruses\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">1<\/a><\/sup>. This shows the urgent need for new antiviral drugs and <b>clinical trials<\/b>.<\/p>\n<p>Knowing about hepatitis C is crucial for your health. A potential vaccine offers hope to those at risk of serious <b>liver disease<\/b><sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.fda.gov\/vaccines-blood-biologics\/science-research-biologics\/new-approaches-development-and-evaluation-vaccines-against-hepatitis-viruses\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">1<\/a><\/sup>.<\/p>\n<h3>Key Takeaways<\/h3>\n<ul>\n<li>HCV affects millions globally, with significant health implications<\/li>\n<li>Developing an effective <b>hepatitis C vaccine<\/b> remains a top medical priority<\/li>\n<li>Current treatments show promise but cannot prevent initial infection<\/li>\n<li>Ongoing research focuses on understanding virus complexities<\/li>\n<li><b>Prevention strategies<\/b> are crucial in managing HCV spread<\/li>\n<\/ul>\n<h2>Understanding HCV and Global Health Impact<\/h2>\n<p><b>Viral hepatitis<\/b> remains a major global health challenge. HCV presents complex <b>prevention strategies<\/b> and critical medical implications. Your grasp of this <b>chronic infection<\/b> can greatly impact public health awareness.<\/p>\n<p>HCV\\&#8217;s global impact reveals startling statistics. About 50 million people have chronic HCV infection worldwide. Each year, roughly 1.0 million new infections occur<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">3<\/a><\/sup>.<\/p>\n<p>In 2022, HCV claimed approximately 242,000 lives. These deaths were mainly due to cirrhosis and hepatocellular carcinoma<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">3<\/a><\/sup>.<\/p>\n<h3>Current Statistics and Disease Burden<\/h3>\n<p>Key metrics help us understand the disease burden:<\/p>\n<ul>\n<li>Chronic HCV infection affects 130-150 million individuals worldwide<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4716084\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">4<\/a><\/sup><\/li>\n<li>Approximately 85% of infected individuals progress to <b>chronic infection<\/b><sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4716084\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">4<\/a><\/sup><\/li>\n<li>In the United States, around 18,000 new HCV infections occur annually<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4716084\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">4<\/a><\/sup><\/li>\n<\/ul>\n<h3>Transmission Routes and Risk Factors<\/h3>\n<p>HCV spreads through various routes, creating complex prevention challenges. Blood transfusions, unsafe medical procedures, and injection drug use are primary transmission methods.<\/p>\n<table>\n<tr>\n<th>Transmission Route<\/th>\n<th>Risk Level<\/th>\n<\/tr>\n<tr>\n<td>Blood Transfusion<\/td>\n<td>High<\/td>\n<\/tr>\n<tr>\n<td>Injection Drug Use<\/td>\n<td>Very High<\/td>\n<\/tr>\n<tr>\n<td>Healthcare Procedures<\/td>\n<td>Moderate<\/td>\n<\/tr>\n<\/table>\n<h3>Challenges in HCV Prevention<\/h3>\n<p><b>Vaccine development<\/b> faces significant hurdles in fighting this virus. HCV\\&#8217;s genetic diversity complicates <b>immune response<\/b> strategies. There are seven known genotypes and over 80 subtypes<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6340767\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">5<\/a><\/sup>.<\/p>\n<p>Despite these challenges, researchers are committed to developing effective preventive measures. Their goal is to create solutions that work against all HCV variants.<\/p>\n<blockquote><p>An effective preventive vaccine could dramatically reduce global HCV incidence and advance worldwide health control<sup class=\\\"citation\\\"><a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6340767\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">5<\/a><\/sup>.<\/p><\/blockquote>\n<p>Your knowledge of HCV can support broader prevention efforts. It can also help ongoing research into this critical public health issue.<\/p>\n<h2>Hepatitis C Vaccine Development Progress<\/h2>\n<p>Medical researchers face a tough task in developing a <b>viral hepatitis<\/b> vaccine. The <b>hepatitis C virus<\/b> is tricky due to its genetic variety and quick mutations<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.medicalnewstoday.com\/articles\/323537\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">6<\/a><\/sup>. Scientists are trying new ways to create an effective <b>immune response<\/b> against this stubborn virus.<\/p>\n<p>Experts are pushing boundaries in <a href=\\\"https:\/\/www.nature.com\/articles\/s41541-023-00635-9\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">vaccine development research<\/a><sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.contagionlive.com\/view\/advances-may-pave-the-way-for-an-hcv-vaccine\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">7<\/a><\/sup>. They\\&#8217;re exploring innovative strategies to tackle this persistent health challenge.<\/p>\n<p><div class=\"ast-oembed-container \" style=\"height: 100%;\"><iframe loading=\"lazy\" title=\"Vaccines Against Hepatitis C Virus | Harnessing Immunity to Eliminate Global Hepatitis C | Day One\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/KRsdNVWpHhk?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/p>\n<p>Current <b>vaccine development<\/b> approaches focus on several critical strategies:<\/p>\n<ul>\n<li>Targeting genetically conserved viral regions<\/li>\n<li>Inducing broadly reactive immune responses<\/li>\n<li>Developing advanced <b>antiviral medications<\/b><\/li>\n<li>Creating comprehensive <b>prevention strategies<\/b><\/li>\n<\/ul>\n<p><b>Clinical trials<\/b> face key challenges. The virus can mutate quickly, making it hard to target. Also, there are limited animal models for testing<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.medicalnewstoday.com\/articles\/323537\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">6<\/a><\/sup>.<\/p>\n<p>About 80% of chronic HCV infections go undetected. This shows the urgent need for effective prevention methods<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.contagionlive.com\/view\/advances-may-pave-the-way-for-an-hcv-vaccine\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">7<\/a><\/sup>.<\/p>\n<table>\n<tr>\n<th>Vaccine Development Approach<\/th>\n<th>Key Characteristics<\/th>\n<\/tr>\n<tr>\n<td>Envelope Protein Vaccines<\/td>\n<td>Target surface proteins to block viral entry<\/td>\n<\/tr>\n<tr>\n<td>Virus-Vectored Vaccines<\/td>\n<td>Use modified viruses to deliver protective antigens<\/td>\n<\/tr>\n<tr>\n<td>mRNA Vaccine Candidates<\/td>\n<td>Innovative approach using messenger RNA technology<\/td>\n<\/tr>\n<\/table>\n<p>The global health community is committed to developing a vaccine. An estimated 71 million people worldwide are infected with hepatitis C<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.mdpi.com\/1999-4915\/13\/8\/1596\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">8<\/a><\/sup>. A successful vaccine could have a huge impact.<\/p>\n<p>Researchers are exploring methods to boost immune responses. They aim to generate powerful cellular immunity and neutralizing antibodies <em>to control hepatitis C long-term<\/em>.<\/p>\n<blockquote><p>The key to vaccine success lies in understanding the virus\\&#8217;s complex immune evasion mechanisms.<\/p><\/blockquote>\n<p>Prevention strategies remain crucial while vaccine research continues. Scientists combine ongoing <b>clinical trials<\/b> with advanced <b>antiviral medications<\/b>. These efforts, along with innovative research, bring us closer to a breakthrough in hepatitis C prevention<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.contagionlive.com\/view\/advances-may-pave-the-way-for-an-hcv-vaccine\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">7<\/a><\/sup>.<\/p>\n<h2>Conclusion<\/h2>\n<p>A <b>Hepatitis C Vaccine<\/b> is crucial for global health. It\\&#8217;s needed to prevent <b>chronic infection<\/b> in high-risk groups. Understanding <b>vaccine development<\/b> is vital to tackle this complex virus.<\/p>\n<p>Clinical trials explore new ways to prevent Hepatitis C. These focus on specific viral traits. <a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2966876\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">Research shows that even<\/a> a 30% effective vaccine could greatly reduce<sup class=\\\"citation\\\"><a href=\\\"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1411-9\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">9<\/a><\/sup>.<\/p>\n<p>Over 185 million people worldwide have Hepatitis C<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.mdpi.com\/1999-4915\/16\/8\/1337\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">10<\/a><\/sup>. A vaccine is urgently needed. It could help protect healthcare workers and people who inject drugs.<\/p>\n<p>Global teamwork is key to solving this health issue. Scientists study antibody responses and viral genetics. Your support can speed up progress in fighting Hepatitis C<sup class=\\\"citation\\\"><a href=\\\"https:\/\/www.mdpi.com\/1999-4915\/16\/8\/1337\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">10<\/a><\/sup>.<\/p>\n<section class=\\\"schema-section\\\">\n<h2>FAQ<\/h2>\n<div>\n<h3>What is Hepatitis C, and how does it affect people?<\/h3>\n<div>\n<div>\n<p>Hepatitis C is a viral infection that mainly affects the liver. It often becomes chronic and can cause serious health issues. The virus rapidly produces millions of particles daily and has many genetic variations.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>How is Hepatitis C transmitted?<\/h3>\n<div>\n<div>\n<p>HCV spreads through blood-to-blood contact in various ways. These include blood transfusions, drug use, and unsafe medical procedures.<\/p>\n<p>Certain groups face higher risks. These include healthcare workers, drug users, and those with multiple sexual partners.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Why is developing a Hepatitis C vaccine so challenging?<\/h3>\n<div>\n<div>\n<p>The virus\\&#8217;s high genetic diversity makes vaccine development difficult. Limited animal testing models and incomplete understanding of immune responses add to the challenge.<\/p>\n<p>The virus can effectively dodge immune system defenses. This makes creating a universally effective vaccine across different strains tough.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Are there current treatments available for Hepatitis C?<\/h3>\n<div>\n<div>\n<p>Yes, doctors use direct-acting antivirals (DAAs) to treat HCV. However, these treatments have drawbacks like high costs and potential resistance.<\/p>\n<p>Researchers stress the need for a preventive vaccine. This could overcome the limitations of current treatments.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>What progress has been made in Hepatitis C vaccine research?<\/h3>\n<div>\n<div>\n<p>Scientists are exploring various vaccine strategies. These include adjuvant envelope, core protein, and virus-vectored nonstructural antigen vaccines.<\/p>\n<p>Current research aims to trigger broad immune responses. It also targets conserved viral regions to develop effective preventive or therapeutic vaccines.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>Who is most at risk for Hepatitis C?<\/h3>\n<div>\n<div>\n<p>High-risk groups include drug users, men who have sex with men, and healthcare workers. Babies born to infected mothers and people with multiple sexual partners are also at risk.<\/p>\n<p>These groups have higher exposure chances. They would benefit most from a potential vaccine.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>What is the global impact of Hepatitis C?<\/h3>\n<div>\n<div>\n<p>Hepatitis C affects about 3.2 million Americans and over 150 million people worldwide. The World Health Organization aims to cut new infections by 90% by 2030.<\/p>\n<p>The virus is a major risk factor for liver cancer. This makes its prevention a critical global health priority.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h3>What are the long-term goals of HCV vaccine development?<\/h3>\n<div>\n<div>\n<p>The main goals are to create a vaccine that prevents transmission and reduces global disease burden. Researchers aim to provide protection across different viral types.<\/p>\n<p>Even a moderately effective vaccine could significantly impact transmission rates. This would be especially true if given to high-risk seronegative individuals.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<h2>Source Links<\/h2>\n<ol data-type=\\\"sources\\\">\n<li>New Methods to Measure the S&amp;E of Hepatitis Vaccines &#8211; <a href=\\\"https:\/\/www.fda.gov\/vaccines-blood-biologics\/science-research-biologics\/new-approaches-development-and-evaluation-vaccines-against-hepatitis-viruses\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.fda.gov\/vaccines-blood-biologics\/science-research-biologics\/new-approaches-development-and-evaluation-vaccines-against-hepatitis-viruses<\/a><\/li>\n<li>Hepatitis C Prevention and Control &#8211; <a href=\\\"https:\/\/www.cdc.gov\/hepatitis-c\/prevention\/index.html\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.cdc.gov\/hepatitis-c\/prevention\/index.html<\/a><\/li>\n<li>Hepatitis C &#8211; <a href=\\\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c<\/a><\/li>\n<li>Status of hepatitis C virus vaccination: Recent update &#8211; <a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4716084\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4716084\/<\/a><\/li>\n<li>Approaches, Progress, and Challenges to Hepatitis C Vaccine Development &#8211; <a href=\\\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6340767\/\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6340767\/<\/a><\/li>\n<li>Hepatitis C vaccine: How is it developing and is it possible? &#8211; <a href=\\\"https:\/\/www.medicalnewstoday.com\/articles\/323537\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.medicalnewstoday.com\/articles\/323537<\/a><\/li>\n<li>Advances May Pave the Way for an HCV Vaccine &#8211; <a href=\\\"https:\/\/www.contagionlive.com\/view\/advances-may-pave-the-way-for-an-hcv-vaccine\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.contagionlive.com\/view\/advances-may-pave-the-way-for-an-hcv-vaccine<\/a><\/li>\n<li>Hepatitis C Virus Vaccine Research: Time to Put Up or Shut Up &#8211; <a href=\\\"https:\/\/www.mdpi.com\/1999-4915\/13\/8\/1596\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.mdpi.com\/1999-4915\/13\/8\/1596<\/a><\/li>\n<li>The case for a universal hepatitis C vaccine to achieve hepatitis C elimination &#8211; BMC Medicine &#8211; <a href=\\\"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1411-9\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1411-9<\/a><\/li>\n<li>Update on Hepatitis C Vaccine: Results and Challenges &#8211; <a href=\\\"https:\/\/www.mdpi.com\/1999-4915\/16\/8\/1337\\\" target=\\\"_blank\\\" rel=\\\"nofollow\\\">https:\/\/www.mdpi.com\/1999-4915\/16\/8\/1337<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Discover the latest breakthroughs in Hepatitis C Vaccine development, prevention strategies, and treatment options to protect yourself against this viral infection.<\/p>\n","protected":false},"author":1,"featured_media":16530,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[998,919,999,1000,1001,240,1002,1003,1004],"class_list":["post-16528","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-emerging-treatments","tag-hepatitis-c-prevention","tag-hepatitis-c-research","tag-immunization-efforts","tag-infectious-diseases","tag-liver-health","tag-public-health-initiatives","tag-vaccine-development","tag-viral-infections"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"wpmanag984","author_link":"https:\/\/www.info-welt.com\/en\/author\/wpmanag984\/"},"uagb_comment_info":0,"uagb_excerpt":"Discover the latest breakthroughs in Hepatitis C Vaccine development, prevention strategies, and treatment options to protect yourself against this viral infection.","_links":{"self":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/posts\/16528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/comments?post=16528"}],"version-history":[{"count":0,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/posts\/16528\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/media?parent=16528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/categories?post=16528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.info-welt.com\/en\/index.php\/wp-json\/wp\/v2\/tags?post=16528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}